11:07 AM EDT, 08/22/2024 (MT Newswires) -- European equities traded in the US as American depositary receipts were relatively flat late Thursday morning, nudging 0.07% higher to 1,461.21 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by internet browser company Opera (OPRA) and biopharmaceutical company Grifols ( GRFS ) , which climbed 16% and 11%, respectively. They were followed by pharmaceutical company Ascendis Pharma ( ASND ) and biotech firm Evaxion Biotech ( EVAX ) , which rose 4.2% and 1.9%, respectively.

The decliners from continental Europe were led by semiconductor company Sequans Communications (SQNS) and biopharmaceutical company Cellectis (CLLS), which lost 3.7% and 2.3%, respectively. They were followed by biopharmaceutical company Genfit (GNFT) and petroleum refiner Equinor (EQNR), which were down 1.8% each.

From the UK and Ireland, the gainers were led by biopharmaceutical companies TC Biopharm ( TCBP ) and Akari Therapeutics ( AKTX ) , which rose 4.4% and 1.7%, respectively. They were followed by biopharmaceutical company Bicycle Therapeutics ( BCYC ) and biotech firm Autolus Therapeutics ( AUTL ) , which were up 1.2% and 1%, respectively.

The decliners from the UK and Ireland were led by biotech firm Trinity Biotech ( TRIB ) and biopharmaceutical company NuCana ( NCNA ) , which dropped 5.8% and 4.7%, respectively. They were followed by biopharmaceutical companies Biodexa Pharmaceuticals ( BDRX ) and Verona Pharma ( VRNA ) , which fell 4.2% and 1.8%, respectively.